For instance, an emerging literature indicates that selective serotonin reuptake inhibitors (SSRIs) may mediate broader mechanisms, such as inflammatory CD4+ T cell reactivity and vascular/platelet reactivity, which underlie both depression and preeclampsia pathogenesis [44,45]. This evidence concerns the gene CD4 and preeclampsia.